Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting MDM2 for Neuroblastoma Therapy: In Vitro and In Vivo Anticancer Activity and Mechanism of Action
Wei Wang, Xinjie Wang, Mehrdad Rajaei, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3651-3651
Open Access | Times Cited: 9

Showing 9 citing articles:

Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research
Rishabh Sharma, Jaya Yadav, Sajad Ahmad Bhat, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Extracellular vesicles in endometriosis: role and potential
Xinying Chu, Menghui Hou, Ying Li, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 5
Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention
Chee Wai Fhu, Azhar Ali
Cancers (2021) Vol. 13, Iss. 7, pp. 1513-1513
Open Access | Times Cited: 36
Exosomal lncRNA CHL1-AS1 Derived from Peritoneal Macrophages Promotes the Progression of Endometriosis via the miR-610/MDM2 Axis
Ting Liu, Mei Liu, Caihua Zheng, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 5451-5464
Open Access | Times Cited: 26
Neuroblastoma in the Era of Precision Medicine: A Clinical Review
Andrew Wahba, Russ Wolters, Jennifer H. Foster
Cancers (2023) Vol. 15, Iss. 19, pp. 4722-4722
Open Access | Times Cited: 8
Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
BioFactors (2023) Vol. 49, Iss. 4, pp. 782-819
Closed Access | Times Cited: 4
In Vitro Assessment of the Role of p53 on Chemotherapy Treatments in Neuroblastoma Cell Lines
Idoia Blanco‐Luquin, Paula Lázcoz, Jon Celay, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1184-1184
Open Access | Times Cited: 4
Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?
Wei Wang, Yi Du, Sayantap Datta, et al.
Genes & Diseases (2023) Vol. 12, Iss. 2, pp. 101156-101156
Open Access | Times Cited: 1
From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma
Bieke Decaesteker, Kaat Durinck, Nadine Van Roy, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 12, pp. 1286-1286
Open Access | Times Cited: 3
Page 1

Scroll to top